{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10913589", "DateCompleted": {"Year": "2000", "Month": "10", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "400", "Issue": "1", "PubDate": {"Year": "2000", "Month": "Jul", "Day": "14"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice.", "Pagination": {"StartPage": "89", "EndPage": "97", "MedlinePgn": "89-97"}, "Abstract": {"AbstractText": ["The antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, were examined in mice. The p.o. administration of N. sativa oil (50-400 mg/kg) dose-dependently suppressed the nociceptive response in the hot-plate test, tail-pinch test, acetic acid-induced writhing test and in the early phase of the formalin test. The systemic administration (2.5-10 mg/kg, p.o. and 1-6 mg/kg, i.p.) and the i.c.v. injection (1-4 microgram/mouse) of thymoquinone attenuated the nociceptive response in not only the early phase but also the late phase of the formalin test. Naloxone injected s.c. (1 mg/kg) significantly blocked N. sativa oil- and thymoquinone-induced antinociception in the early phase of the formalin test. Moreover, the i.c.v. injection of naloxone (10 microgram/mouse), the mu(1)-opioid receptor antagonist, naloxonazine (1-5 microgram/mouse), or the kappa-opioid receptor antagonist, nor-binaltorphimine (1-5 microgram/mouse), significantly reversed thymoquinone-induced antinociception in the early phase but not the late phase of the formalin test, whereas the delta-opioid receptor antagonist, naltrindole (1-5 ng/mouse, i.c.v.), had no effect on either phase. The antinociceptive effect of morphine was significantly reduced in thymoquinone- and N. sativa oil-tolerant mice, but not vice versa. These results suggest that N. sativa oil and thymoquinone produce antinociceptive effects through indirect activation of the supraspinal mu(1)- and kappa-opioid receptor subtypes."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, 930-0194, Toyama, Japan."}], "Identifier": [], "LastName": "Abdel-Fattah", "ForeName": "A M", "Initials": "AM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Matsumoto", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Watanabe", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics, Non-Narcotic"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzoquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Oils"}, {"RegistryNumber": "36B82AMQ7N", "NameOfSubstance": "Naloxone"}, {"RegistryNumber": "5S6W795CQM", "NameOfSubstance": "Naltrexone"}, {"RegistryNumber": "G167Z38QA4", "NameOfSubstance": "naltrindole"}, {"RegistryNumber": "O60IE26NUF", "NameOfSubstance": "thymoquinone"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Analgesics, Non-Narcotic"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzoquinones"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Tolerance"}, {"QualifierName": [], "DescriptorName": "Injections, Intraventricular"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Motor Activity"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Naloxone"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Naltrexone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Oils"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "7", "Day": "29", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "10", "Day": "14", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "7", "Day": "29", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10913589", "10.1016/s0014-2999(00)00340-x", "S001429990000340X"]}}], "PubmedBookArticle": []}